The Food and Drug Administration approved the new coronary plasma therapy, saying its benefits outweigh the risks

BEIJING, Aug. 24 (Xinhua Chinese) -- U.S. President Donald Trump announced at a White House press conference Wednesday evening that the U.S. Food and Drug Administration (FDA) has approved the use of plasma therapy in the treatment of new crown patients.
, Trump reportedly said at a news conference the same day, "This (plasma therapy) is a powerful treatment, from the blood of recovering patients to convert very strong antibodies, to help infected people with the (new coronavirus)
." The
said in a statement that "the known and potential benefits of the therapy outweigh the known and potential risks," according to the report. The FDA also said the plasma was made from the blood of patients recovering from the new crown, and that more than 70,000 patients have been treated with plasma.
addition, in response to the U.S. government's response to the new crown outbreak, a new poll released on the 23rd showed that 73 percent of Republicans think the response is going well, while only 38 percent of all respondents agreed. On the other hand, 62 percent of voters said the U.S. response to the new outbreak was "terrible," but only 27 percent of Republicans said so.
poll results showed clear differences between Republican respondents and others over the U.S. government's response, the Associated Press reported.
. As of 7:27 a.m. Beijing time on August 24, there were more than 5.69 million confirmed cases and more than 176,000 deaths in the U.S., according to real-time statistics from Johns Hopkins University.